Everand Logo

Welcome to Everand!

  • STAT

    A new wave of pharma mergers could put innovative drugs in the pipeline

    In the pharmaceutical industry, large mergers generally increase research and development productivity and boost the number of new drugs in the pipeline.
    by Michael S. Ringel and Michael K. Choy Jul 24, 2017 3 minutes
    Source: APStock

    A new wave of pharmaceutical industry mergers may be on the horizon, in part driven by the $1.3 trillion in overseas cash that U.S. corporations currently hold. If policymakers provide a tax holiday on repatriation of these funds, some experts say that U.S. pharmaceutical companies would be flush with cash and could likely spend a meaningful portion of this windfall on mergers.

    While big mergers could have many impacts — on employment at home and abroad, competition, and drug prices, to name a few — one of the most important would be the

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About FDA Dithering On Pharma Patents, WHO Pandemic Talks, And More
    When it comes to a crucial controversy over patents for drug-and-device combination products, the FDA has been MIA.
    STAT1 min read
    STAT+: Element Biosciences, An Illumina Rival, On Its Genomics Ambitions — And Why It Hasn’t Gone Public
    Element Biosciences' modest growth comes at a time when some other players are struggling in a sequencer market dominated by Illumina.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About A Boy Dying In Pfizer Trial; AstraZeneca Yanking Covid Shot, And More
    A young boy died in a clinical trial for an experimental Pfizer gene therapy for Duchenne muscular dystrophy, about a year after receiving the therapy.

    Related Books & Audiobooks